GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Health & Life Co Ltd (ROCO:1781) » Definitions » Debt-to-Equity

Health & Life Co (ROCO:1781) Debt-to-Equity : 0.31 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Health & Life Co Debt-to-Equity?

Health & Life Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$89.4 Mil. Health & Life Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$18.5 Mil. Health & Life Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was NT$349.1 Mil. Health & Life Co's debt to equity for the quarter that ended in Mar. 2024 was 0.31.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Health & Life Co's Debt-to-Equity or its related term are showing as below:

ROCO:1781' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.29   Max: 0.61
Current: 0.31

During the past 13 years, the highest Debt-to-Equity Ratio of Health & Life Co was 0.61. The lowest was 0.00. And the median was 0.29.

ROCO:1781's Debt-to-Equity is ranked worse than
57.31% of 698 companies
in the Medical Devices & Instruments industry
Industry Median: 0.215 vs ROCO:1781: 0.31

Health & Life Co Debt-to-Equity Historical Data

The historical data trend for Health & Life Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health & Life Co Debt-to-Equity Chart

Health & Life Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 0.46 0.36 0.51 0.34

Health & Life Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.46 0.42 0.34 0.31

Competitive Comparison of Health & Life Co's Debt-to-Equity

For the Medical Devices subindustry, Health & Life Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health & Life Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Health & Life Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Health & Life Co's Debt-to-Equity falls into.



Health & Life Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Health & Life Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Health & Life Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Health & Life Co  (ROCO:1781) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Health & Life Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Health & Life Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Health & Life Co (ROCO:1781) Business Description

Traded in Other Exchanges
N/A
Address
Jian 1st Road, 9th Floor, No-186, New Taipei City, TWN
Health & Life Co Ltd manufactures medical devices in the fields of cardiovascular disease and in-vitro diagnostics in Taiwan. Its product portfolio includes blood pressure monitor series, nebulizer, and blood glucose monitoring system, blood glucose stripes and Thermometer.

Health & Life Co (ROCO:1781) Headlines

No Headlines